Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 35

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

614

HTML

5939

Figures (1-5)

227

Tables (1-1)

134

Sum=6914

Sep 21, 2010 (publication date) through Apr 30, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Sep 21, 2010; 16(35): 4410-4415
Published online Sep 21, 2010. doi: 10.3748/wjg.v16.i35.4410

Table 1 Clinical data about the patients included in the study

^aP > 0.05. HCC: Hepatocellular carcinoma; HBV: Hepatitis B virus; HCV: Hepatitis C virus; BCLC: Barcelona Clinic Liver Cancer.

Citation: Liu H, Li P, Zhai Y, Qu CF, Zhang LJ, Tan YF, Li N, Ding HG. Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma. World J Gastroenterol 2010; 16(35): 4410-4415
URL: https://www.wjgnet.com/1007-9327/full/v16/i35/4410.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i35.4410